Kerstin Gagaring

Scripps Research Institute — United States

Medicine · Health Sciences

18h-index2.0kcitations23works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(12), Mosquito-borne diseases and control(5), Computational Drug Discovery Methods(5), Synthesis and Catalytic Reactions(5), Microbial Natural Products and Biosynthesis(3)

Publications23 total

Antimalarial Peptide and Polyketide Natural Products from the Fijian Marine Cyanobacterium Moorea producens
Marine Drugs·2020· 43 citedOpen Access
Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials
ACS Infectious Diseases·2020· 39 citedOpen Access
Peyssonnosides A–B, Unusual Diterpene Glycosides with a Sterically Encumbered Cyclopropane Motif: Structure Elucidation Using an Integrated Spectroscopic and Computational Workflow
The Journal of Organic Chemistry·2019· 40 citedOpen Access
Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections
Science Translational Medicine·2019· 44 cited
Modular, stereocontrolled C <sub>β</sub> –H/C <sub>α</sub> –C activation of alkyl carboxylic acids
Proceedings of the National Academy of Sciences·2019· 52 citedOpen Access
Antibacterial Oligomeric Polyphenols from the Green Alga <i>Cladophora socialis</i>
The Journal of Organic Chemistry·2019· 24 citedOpen Access
Modular, Stereocontrolled Cβ–H/Cα–C Activation of Alkyl Carboxylic Acids
2019Open Access
Modular, Stereocontrolled Cβ–H/Cα–C Activation of Alkyl Carboxylic Acids
2019Open Access
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials
Science·2018· 137 citedOpen Access
IDENTIFICATION OF A DUAL LIVER-ASEXUAL STAGE ANTIMALARIAL TARGETING PFDHODH
American Journal of Tropical Medicine and Hygiene·2018
High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria
ACS Infectious Diseases·2016· 103 citedOpen Access
Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials
ACS Chemical Biology·2014· 98 citedOpen Access
Lead Optimization of Imidazopyrazines: A New Class of Antimalarial with Activity on <i>Plasmodium</i> Liver Stages
ACS Medicinal Chemistry Letters·2014· 33 cited
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Antimicrobial Agents and Chemotherapy·2014· 154 citedOpen Access
KAI407, a Potent Non-8-Aminoquinoline Compound That Kills Plasmodium cynomolgi Early Dormant Liver Stage Parasites<i>In Vitro</i>
Antimicrobial Agents and Chemotherapy·2013· 69 citedOpen Access
Targeting Plasmodium phosphatidylinositol-4 kinase for the treatment, prevention and elimination of malaria
2013
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
Science Translational Medicine·2013· 149 cited
Targeting Plasmodium PI(4)K to eliminate malaria
Nature·2013· 419 citedOpen Access
Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents
Journal of Medicinal Chemistry·2012· 92 citedOpen Access
Imaging of <i>Plasmodium</i> Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Science·2011· 347 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Case W. McNamara(17), Kelli Kuhen(13), Elizabeth A. Winzeler(13), Arnab K. Chatterjee(12), David Plouffe(11), Richard Glynne(10), Thierry T. Diagana(9), A. S. Nagle(8), Rachel Borboa(8), Jason Roland(6), Nobutaka Kato(6), Stephan Meister(6), David A. Fidock(6), Matthias Rottmann(5), David C. Tully(5), Anne‐Marie Zeeman(4), Maureen Ibanez(4), François Nosten(4), Clemens H. M. Kocken(4), Tove Tuntland(4)